|
Company Report
|
 Biopartnering Strategies: Maximizing returns from biotechnology deal-making
Biopartnering Strategies is a unique report from the Drug Discovery series that provides an essential guide to the biopartnering process, for both in-licensing and out-licensing companies.
|
|
Read more...
|
|
|
Product Report
|
Innovations in CNS: Novel therapeutics and future RandD strategies
The CNS drug market presents significant profit opportunities, but also carries high risks for companies aiming to achieve blockbuster status.
|
|
Read more...
|
|
|
Market Report
|
The Cardiovascular Market Outlook to 2011
The Cardiovascular Market Outlook to 2011 is a new report from Business Insights providing analysis of the current and future market for cardiovascular drugs across all major indications. Forecasts are given based on new product launches, upcoming patent expiry dates, and ongoing clinical trials to enable you to predict changes in the dynamics of the global cardiovascular market.
|
|
Read more...
|
|
|
Market Report
|
Innovations in Cancer: Novel therapeutics, new diagnostics and future RandD strategies
The cancer market is highly dynamic, creating a new age of discovery and innovation driven by molecular biology, oncogenomics and new methods in cell biology.
|
|
Read more...
|
|
|
Product Report
|
Next Generation Protein Engineering & Drug Design: Strategies to boost efficacy
The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market, spurring the creation of next-generation products with reduced immunogenicity, improved safety and greater effectiveness.
|
|
Read more...
|
|
|
Market Report
|
The Dermatology Market Outlook to 2011
The Dermatology Market Outlook to 2011 provides detailed analysis on 5 indications within the dermatology market, identifying high growth brands, future market leaders and key drug classes.
|
|
Read more...
|
|
|
Market Report
|
eHealth Solutions for Pharma: Strategies for salesforces, marketing and patient compliance
The online channel offers a key opportunity for pharma companies to restructure their sales and marketing model, improving their relationships with physicians and increasing compliance among patients.
|
|
Read more...
|
|
|
Company Report
|
Indication Expansion: Opportunities for successful lifecycle management
Due to shrinking pipelines and rising financial pressures on pharmaceutical companies, indication expansion is an increasingly attractive strategy to expand patient potential and extend market exclusivity.
|
|
Read more...
|
|
|
Product Report
|
Winning Product Launch Strategies: Maximizing sales from new pharmaceutical products
With pharmaceutical R&D continuing to suffer from declining productivity levels and stagnant returns on investment, effective, flexible and commercially successful new product launches have become more important than ever.
|
|
Read more...
|
|
|
Market Report
|
The Women’s Health Market Outlook to 2011
With increased pricing pressure from generics, limited differentiation among new medicines and pipeline products and declining sales growth, the women’s health market is facing threatening competitive forces, prompting major pharmaceutical players to initiate key strategic changes.
|
|
Read more...
|
|
|
Product Report
|
Drug Repositioning Strategies: Innovative strategies to boost pipeline productivity
Drug repositioning is regarded as the pharma industry’s solution to falling R&D productivity and weakening product pipelines, successful repositioned drugs such as raloxifene (Evista; Lilly), thalidomide (Thalomid; Celegene), (Exubera;Pfizer/Nektar) have enabledinnovative companies to adopt lower risk strategies to optimize product pipelines.
|
|
Read more...
|
|
|
Market Report
|
The Global Anti-Infectives Market Outlook to 2011
The anti-infectives market is forecast to expand at a CAGR of 4.8% over the period 2005-11, riven largely by gains in the anti-bacterial and anti-viral classes. This represents significant market opportunity for pharma companies to expand their sales potential by targeting high growth markets.
|
|
Read more...
|
|
|
Market Report
|
The Indian Pharmaceutical Market to 2011: Competitive dynamics and major players
Traditionally, the Indian pharmaceutical industry has been characterized by a core competency in generics’ manufacturing and relatively immature capabilities in R&D. This outlook has evolved substantially since the 1990s and Indian companies have been making investments towards expanding drug discovery and development capabilities.
|
|
Read more...
|
|
|
Product Report
|
Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players
The highly dynamic cancer market is creating a new age of discovery and innovation driven by molecular biology, oncogenomics and new methods in cell biology. Resultantly, cancer innovatives are not only the fastest growing segment within the cancer market, but the key drivers of sales growth across the pharmaceutical market as a whole.
|
|
Read more...
|
|
|
Market Report
|
The Global HIV/AIDS Market Outlook to 2012
The Global HIV/AIDS Market Outlook to 2012 is a report that provides comprehensive coverage of the global HIV/AIDS market, incorporating a detailed epidemiological analysis of the prevalence of HIV/AIDS and key factors impacting prevalence in both the seven major pharmaceutical markets as well as emerging markets.
|
|
Read more...
|
|
|
Market Report
|
Patent Protection Strategies: Maximising product Revenues
Patent Protection Strategies: Maximising product revenues explores the best methods of exploiting legislation to maximise revenue generation and protecting the considerable investments associated with innovations.
|
|
Read more...
|
|
|
Product Report
|
The Future of Biosimilars: Key opportunities & emerging therapies
Biotechnological products are continuing to exhibit substantial revenue gains, with the top 12 biologics registering sales growth of 20%in 2006, amassing a market share of $64 billion. However, the impending patent expiry of many leading products has created a number of highly attractive market opportunities for biosimilars. To exploit this significant potential, a complex route to market must first be negotiated, including numerous barriers to entry and regulatory hurdles.
|
|
Read more...
|
|
|
Product Report
|
Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs&medical devices
Despite significant advances in prevention and treatment, cardiovascular disease remains the leading cause of death in economically advanced countries. The developing world has also begun to experience a disconcerting growth in prevalence, where the insurgence of CVD has exacerbated the risk factors associated with indigenous communicable diseases.
|
|
Read more...
|
|
Farmavita.Net Journal 
